MCID: PRN029
MIFTS: 34

Parainfluenza Virus Type 3 malady

Category: Rare diseases

Aliases & Classifications for Parainfluenza Virus Type 3

About this section

Aliases & Descriptions for Parainfluenza Virus Type 3:

Name: Parainfluenza Virus Type 3 46
Human Parainfluenza Virus Type 3 46
 
Piv3 46

Classifications:



Summaries for Parainfluenza Virus Type 3

About this section
NIH Rare Diseases:46 Parainfluenza virus type 3 is one of a group of common viruses known as human parainfluenza viruses (hpiv) that cause a variety of respiratory illnesses. symptoms usually develop between 2 and 7 days from the time of exposure and typically resolve in 7-10 days. symptoms may include fever, runny nose, and cough. hpiv-3 can also cause bronchiolitis, bronchitis, and pneumonia. infants and young children are particularly susceptible to hpiv-3 infections, though older adults and those with a weakened immune system are also at risk for complications. hpivs are usually spread from an infected person to others through coughing, sneezing, and/or touching. there is currently no vaccine to protect against parainfluenza virus infections. most hpiv infections resolve on their own and do not require special treatment, though medical intervention may be necessary for severe breathing problems. most adults have antibodies against parainfluenza but can get repeat infections. last updated: 8/30/2016

MalaCards based summary: Parainfluenza Virus Type 3, also known as human parainfluenza virus type 3, is related to fetal parainfluenza virus type 3 syndrome and pneumonia. An important gene associated with Parainfluenza Virus Type 3 is NEU1 (Neuraminidase 1), and among its related pathways are Type II interferon signaling (IFNG) and NF-kappa B signaling pathway. Affiliated tissues include testes, lung and t cells, and related mouse phenotype hematopoietic system.

Related Diseases for Parainfluenza Virus Type 3

About this section

Graphical network of the top 20 diseases related to Parainfluenza Virus Type 3:



Diseases related to parainfluenza virus type 3

Symptoms for Parainfluenza Virus Type 3

About this section

Drugs & Therapeutics for Parainfluenza Virus Type 3

About this section

Drugs for Parainfluenza Virus Type 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1vitamin dPhase 31607
2
ErgocalciferolNutraceuticalPhase 3121150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
3
CholecalciferolNutraceuticalPhase 382667-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Maternal Vitamin D for Acute Respiratory Infections in InfancyActive, not recruitingNCT02388516Phase 3
2A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old InfantsCompletedNCT00686075Phase 1, Phase 2
3A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of AgeTerminatedNCT00508651Phase 1, Phase 2
4Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and AdultsCompletedNCT00366782Phase 1
5Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy ChildrenCompletedNCT00345670Phase 1
6Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and ChildrenCompletedNCT01254175Phase 1
7Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of AgeCompletedNCT00493285Phase 1
8Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenCompletedNCT01021397Phase 1
9Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy InfantsCompletedNCT00308412Phase 1
10Study to Evaluate MEDI-534 in Healthy AdultsCompletedNCT00111878Phase 1
11Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus VaccineCompletedNCT00641017Phase 1
12A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and ToddlersRecruitingNCT00186927Phase 1
13Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy AdultsActive, not recruitingNCT02564575Phase 1
14Collection and Testing of Respiratory SamplesCompletedNCT01302418

Search NIH Clinical Center for Parainfluenza Virus Type 3

Genetic Tests for Parainfluenza Virus Type 3

About this section

Anatomical Context for Parainfluenza Virus Type 3

About this section

MalaCards organs/tissues related to Parainfluenza Virus Type 3:

34
Testes, Lung, T cells, Monocytes, Bone, Bone marrow, Liver

Animal Models for Parainfluenza Virus Type 3 or affiliated genes

About this section

MGI Mouse Phenotypes related to Parainfluenza Virus Type 3:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.7DDX58, ICAM1, IFIH1, IFNB1, NEU1

Publications for Parainfluenza Virus Type 3

About this section

Articles related to Parainfluenza Virus Type 3:

(show top 50)    (show all 275)
idTitleAuthorsYear
1
Pathogenicity and horizontal transmission studies of caprine parainfluenza virus type 3 JS2013 strain in goats. (27374058)
2016
2
A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013-2015 in Catalonia, Spain. (27524509)
2016
3
Identification of three antigen epitopes on the nucleocapsid protein of the genotype C of bovine parainfluenza virus type 3. (25960335)
2015
4
Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. (24478424)
2014
5
Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes. (24978141)
2014
6
A novel parainfluenza virus type 3 (PIV3) identified from goat herds with respiratory diseases in eastern China. (25236986)
2014
7
Prevalence of antibodies against Parainfluenza virus type 3, Respiratory syncitial virus and bovine Herpesvirus type 1 in sheep from Northern Prefectures of Japan. (24166480)
2013
8
Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines. (23514887)
2013
9
Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. (21986028)
2011
10
Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: the diagnostic importance of hoarseness and monocytosis. (20888644)
2011
11
Identification of simian agent 10 as human parainfluenza virus type 3 suggests transmission of a human virus to an African monkey. (20881043)
2010
12
Evidence for phosphorylation of human parainfluenza virus type 3 C protein: mutant C proteins exhibit variable inhibitory activities in vitro. (19410612)
2009
13
Outbreak of parainfluenza virus type 3 in a neonatal intensive care unit. (19085679)
2009
14
Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection. (18614637)
2008
15
Inhibition of human parainfluenza virus type 3 infection by novel small molecules. (17964670)
2008
16
Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. (17392447)
2007
17
A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge. (17052811)
2007
18
Roles of human parainfluenza virus type 3 bases 13 to 78 in replication and transcription: identification of an additional replication promoter element and evidence for internal transcription initiation. (16699019)
2006
19
Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3. (16730076)
2006
20
Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. (15613339)
2005
21
Role of a highly conserved NH(2)-terminal domain of the human parainfluenza virus type 3 RNA polymerase. (12134015)
2002
22
Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant. (11462020)
2001
23
A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3. (11601905)
2001
24
Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. (11262213)
2001
25
Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates. (10872880)
2000
26
Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. (10729139)
2000
27
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. (10725212)
2000
28
Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. (10497117)
1999
29
Rescue of Sendai virus cDNA templates with cDNA clones expressing parainfluenza virus type 3 N, P and L proteins. (8887479)
1996
30
Some virological and pathomorphological aspects of the respiratory system in the experimental infection with respiratory syncytial virus associated with influenza virus, parainfluenza virus type 3 and adenovirus in the mouse. (9495783)
1996
31
Human parainfluenza virus type 3: analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion. (7653094)
1995
32
Sequence variation in the haemagglutinin-neuraminidase gene of human parainfluenza virus type 3 isolates in the UK. (7781737)
1995
33
Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. (7769692)
1995
34
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. (8139055)
1994
35
Parainfluenza virus type 3 and pertussis syndrome. (8244477)
1993
36
Parainfluenza virus type 3 (PIV3)-specific and non-virus-specific delayed type hypersensitivity responses in cotton rats given different PIV3 antigen preparations. (8383384)
1993
37
Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis. (8391749)
1993
38
Isolation of parainfluenza virus type 3 from cerebrospinal fluid. (1316416)
1992
39
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. (1310183)
1992
40
Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children. (1323576)
1992
41
Outbreak of parainfluenza virus type 3 in a neonatal nursery. (2153949)
1990
42
Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3. (3005486)
1986
43
Parainfluenza virus type 3 in pigs. (3024379)
1986
44
The effect of parainfluenza virus type 3 on the phagocytic cell response of the ovine lung to Pasteurella haemolytica. (3010545)
1986
45
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. (3016327)
1986
46
Properties of temperature-sensitive mutants of parainfluenza virus type 3 selected during the course of persistent infection. (2986583)
1985
47
Evidence of a T-cell-mediated cytotoxic response to parainfluenza virus type 3 pneumonia in hamsters. (6278144)
1982
48
Parainfluenza virus type 3: isolation from CSF of a patient with Guillain-BarrAc syndrome. (211275)
1978
49
Cytopathic effects of parainfluenza virus Type 3 in organ cultures of human respiratory tract tissue. (4295104)
1968
50
Inhibition of interferon by an infection with parainfluenza virus type 3 (PIV-3). (13953978)
1963

Variations for Parainfluenza Virus Type 3

About this section

Expression for genes affiliated with Parainfluenza Virus Type 3

About this section
Search GEO for disease gene expression data for Parainfluenza Virus Type 3.

Pathways for genes affiliated with Parainfluenza Virus Type 3

About this section

Pathways related to Parainfluenza Virus Type 3 according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5ICAM1, IFNB1
29.3DDX58, ICAM1
3
Show member pathways
8.9DDX58, ICAM1, IFNB1
4
Show member pathways
8.6DDX58, IFIH1, IFNB1
5
Show member pathways
8.6DDX58, IFIH1, IFNB1
6
Show member pathways
8.6DDX58, IFIH1, IFNB1
7
Show member pathways
8.1DDX58, ICAM1, IFIH1, IFNB1

GO Terms for genes affiliated with Parainfluenza Virus Type 3

About this section

Biological processes related to Parainfluenza Virus Type 3 according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1response to exogenous dsRNAGO:00433309.4DDX58, IFNB1
2positive regulation of interferon-alpha productionGO:00327279.3DDX58, IFIH1
3detection of virusGO:00095979.2DDX58, IFIH1
4regulation of type III interferon productionGO:00343449.2DDX58, IFIH1
5negative regulation of type I interferon productionGO:00324809.1DDX58, IFIH1
6cytoplasmic pattern recognition receptor signaling pathway in response to virusGO:00395289.1DDX58, IFIH1
7positive regulation of interferon-beta productionGO:00327288.9DDX58, IFIH1
8response to virusGO:00096158.3DDX58, IFIH1, IFNB1

Molecular functions related to Parainfluenza Virus Type 3 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1single-stranded RNA bindingGO:00037279.0DDX58, IFIH1
2helicase activityGO:00043869.0DDX58, IFIH1
3double-stranded RNA bindingGO:00037258.7DDX58, IFIH1

Sources for Parainfluenza Virus Type 3

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet